SERVICE REQUEST
Quotation Request for Manufacturing Services
Full-Service Peptide & Oligo CDMO
At Sinopep, we provide a streamlined way for researchers and developers to request custom synthesis quotes across three specialized service areas: Peptide, Oligonucleotide, and GMP Peptide manufacturing. Whether you need research-grade materials for discovery, complex oligos with advanced modifications, or phase-appropriate GMP peptide production for clinical and commercial programs, our integrated platform makes it easy to begin your project.
Service Comparison
The table compares Discovery Peptides’ service levels, from standard research-grade peptide synthesis with basic characterization, to advanced GMP manufacturing with full regulatory support, specialized oligonucleotide synthesis (including ASOs, siRNA, modified backbones, and conjugates), and a dedicated Full-Time Equivalent (FTE) team model for long-term projects. It clearly shows how offerings progress from essential analytical and technical services to comprehensive clinical-grade production and scalable, continuous collaboration options.
| Discovery Peptides | GMP Manufacturing | Oligonucleotides | Full-Time Equivalent (FTE) |
|---|---|---|---|
| Standard Services: | Standard Services: | Service Types: | Our FTE Model: |
| ✔ HPLC & MS Characterization | ✔ GMP Peptide Technical Package | ✔ Antisense Oligos (ASOs), siRNA, miRNA | ✔ Continuous Operations |
| ✔ Expert Technical Support | ✔ Regulatory Support | ✔ Morpholino Phosphorodiamidate Oligomers (PMOs) | ✔ Dedicated Team Allocation |
| Available Services: | ✔ Phase-Appropriate Controls | ✔ Aptamers, CpG oligos, Decoys | ✔ Budget Certainty |
| ✔ Conjugation Services | ✔ CMC Documentation for IND/NDA | ✔ Peptide-Oligo Conjugates (POCs) and PPMOs | ✔ Full Data Visibility |
| ✔ Aliquoting Services | ✔ DMF Compilation & Submission | ✔ Backbone: PO, PS, PN | ✔ Administrative Efficiency |
| ✔ Amino Acid Analysis | ✔ Annual Product Reviews | ✔ Base: 2’-OMe, 2’-MOE, 2’-F, 2’-LNA, cEt | ✔ Scalable Flexibility |
| ✔ Solubility Testing | ✔ Operational Continuity: | ||
| ✔ Endotoxin Testing | |||
| ✔ Water Content Analysis |
- 20+
- Years Experience
- 2500+
- Employees
- 50+
- Capacity (MT/yr)
- 3
- GMP Faclities
Inspection History
Since 2014, Sinopep’s GMP manufacturing facilities have successfully passed four (4) inspections conducted by the U.S. FDA, demonstrating our strong commitment to global regulatory compliance and product quality. In addition to these FDA audits, Sinopep has also undergone inspections by the Korean MFDS and has successfully completed 20 regulatory audits conducted by the NMPA in China.
| Date | Inspected Type | Regulatory Agency | Result |
|---|---|---|---|
| Apr 2014 | Peptide API | FDA CGMP | Pass |
| Apr 2016 | Peptide API | FDA CGMP | Pass |
| Jan 2019 | Routine Inspection | FDA CGMP | Pass |
| Nov 2023 | Small Molecule & Peptide API | MFDS CGMP | Pass |
| Sep 2024 | Routine Inspection (Unannounced Inspection) | FDA CGMP | Pass |
| July 2025 | GLP-1 Product-Specific Inspections | ANVISA CGMP | Pass |